INAGURAL DRONTECH ASIA 2024 EVENT TO PROPEL SOUTHEAST ASIA'S UAV INDUSTRY WITH 100+ BRANDS, 15 SESSIONS, AND MULTIPLE DEMONSTRATIONS NEXT WEEK BANGKOK, Nov. 20, 2024 /PRNewswire/ — Supported and attended by the Civil… CISION PRNewswireNovember 20, 2024
Press ReleasePhilips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies SINGAPORE, Nov. 20, 2024 /PRNewswire/ — Philips (NYSE: PHG, AEX: PHIA), a global… CISION PRNewswireNovember 20, 2024
TIER IV launches Minibus 2.0 autonomous EV TOKYO, Nov. 20, 2024 /PRNewswire/ — TIER IV, the pioneering force behind the… CISION PRNewswireNovember 20, 2024
Cargobase Secures SOC 2 Compliance For Leading Spot Freight Automation & Transportation Management System (TMS) SINGAPORE, Nov. 20, 2024 /PRNewswire/ — Cargobase, a logistics technology platform for… CISION PRNewswireNovember 20, 2024
Press ReleaseMiTAC Computing Unveils New AI/HPC-Optimized Servers with Advanced CPU and GPU Integration at SC24 ATLANTA, Nov. 20, 2024 /PRNewswire/ — MiTAC Computing Technology Corporation, an industry-leading… CISION PRNewswireNovember 20, 2024
Press ReleaseHydra X Becomes the first Licensed Custodian in APAC to Provide Custody for Canton Coin SINGAPORE, Nov. 20, 2024 /PRNewswire/ — Hydra X today announced that it is… CISION PRNewswireNovember 20, 2024
Samsung Biologics signs manufacturing deal with European pharmaceutical company The company will provide manufacturing services through 2031 in deals worth over… CISION PRNewswireNovember 20, 2024
Epigenic Therapeutics to Enter Clinical Development of EPI-003: A First-in-Class Epigenetic Inactivator for the Treatment of Chronic Hepatitis B SHANGHAI, Nov. 20, 2024 /PRNewswire/ — Epigenic Therapeutics, a leading biotechnology company… CISION PRNewswireNovember 20, 2024
